Cargando…
Gender Stratified Gene and Gene–Treatment Interactions in Smoking Cessation
We conducted gender-stratified analyses on a systems-based candidate gene study of 53 regions involved in nicotinic response and the brain-reward pathway in two randomized clinical trials of smoking cessation treatments (placebo, bupropion, transdermal and nasal spray nicotine replacement therapy)....
Autores principales: | Lee, Wonho, Bergen, Andrew W., Swan, Gary E., Li, Dalin, Liu, Jinghua, Thomas, Paul, Tyndale, Rachel F., Benowitz, Neal L., Lerman, Caryn, Conti, David V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208134/ https://www.ncbi.nlm.nih.gov/pubmed/21808284 http://dx.doi.org/10.1038/tpj.2011.30 |
Ejemplares similares
-
Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation
por: Conti, David V., et al.
Publicado: (2008) -
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking
por: Tyndale, Rachel F., et al.
Publicado: (2015) -
Dopamine genes and nicotine dependence in treatment seeking and community smokers
por: Bergen, Andrew W., et al.
Publicado: (2009) -
Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans
por: Chenoweth, Meghan J., et al.
Publicado: (2021) -
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012)